33
Participants
Start Date
November 16, 2009
Primary Completion Date
September 13, 2012
Study Completion Date
August 21, 2013
denosumab
120 mg subcutaneously (SC) every 4 weeks with a loading dose of 120 mg SC on study days 8 and 15.
Research Site, New York
Research Site, The Bronx
Research Site, Syracuse
Research Site, Milan
Research Site, Salisbury
Research Site, Goldsboro
Research Site, Durham
Research Site, Montpellier
Research Site, Padua
Research Site, Bologna
Research Site, Nantes
Research Site, Dearborn
Research Site, Detroit
Research Site, Florence
Research Site, Omaha
Research Site, Houston
Research Site, Limoges
Research Site, Encinitas
Research Site, Villejuif
Research Site, New Haven
Research Site, Québec
Research Site, Québec
Research Site, Roma
Research Site, Warsaw
Lead Sponsor
Amgen
INDUSTRY